Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Machine learning can help post-childbirth mothers guard against problems with subsequent pregnancies, potentially saving their lives and those of their future babies.
Trotting out a new digital health assistant this week, Amazon is emphasizing the wearable’s incorporation of AI to guide users toward some complicated goals.
Researchers in Canada are working to develop AI models for diagnosing and treating mental illness. One application in their sights involves automated interpretations of brain scans.
When a virus mutates, the researchers explained, it can be benign or even make the virus less dangerous to humans. In this instance, however, many detected mutations have a significant chance of becoming more infectious strains of COVID-19.
Along with new or improved algorithmic applications for chest imaging, watch for word of an AI-powered breathalyzer and other diagnostic techno-weapons aimed at COVID. What they’ll all have in common is full-throated NIH support.
Computerized clinical decision support has strong upsides and few to no downsides for both clinicians and patients, according to a systematic literature review.
Researchers at New York University have demonstrated an AI-based way to send COVID patients from the ER to the most appropriate care setting according to their individualized risk.
Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.
The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals.
As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”
